Randall C. Schatzman, President and CEO at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 15,168 shares at $30.65 ($470K) on 2016-08-01, disclosed to the SEC on 2016-08-03.
Open-market sale of $470k ALDR by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.65 | 5,168 | $158K | 33.7% |
| 2 | $30.65 | 5,168 | $158K | 33.7% |
| 3 | $31.68 | 4,816 | $153K | 32.5% |
| 4 | $32.69 | 16 | $523 | 0.1% |
| Total | $30.98 avg | 15,168 | $470K | 100% |
| Filing → |
| ALDR | SELL | 2016-11-09 | $252K | — | Filing → |
| ALDR | SELL | 2016-10-05 | $424K | — | Filing → |
| ALDR | SELL | 2016-09-06 | $650K | — | Filing → |